{"id":2550,"date":"2017-10-12T16:12:00","date_gmt":"2017-10-12T16:12:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2550"},"modified":"2025-01-15T03:25:30","modified_gmt":"2025-01-15T03:25:30","slug":"scenarios-to-manage-the-hepatitis-c-disease-burden-and-associated-economic-impact-of-treatment-in-turkey","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/scenarios-to-manage-the-hepatitis-c-disease-burden-and-associated-economic-impact-of-treatment-in-turkey\/","title":{"rendered":"Sc\u00e9narios pour g\u00e9rer le fardeau de l'h\u00e9patite C et l'impact \u00e9conomique associ\u00e9 du traitement en Turquie"},"content":{"rendered":"

R\u00e9sum\u00e9<\/h2>\n\n\n\n

Arri\u00e8re-plan<\/h3>\n\n\n\n

L'infection par le virus de l'h\u00e9patite C (VHC) est un probl\u00e8me de sant\u00e9 important. Le but de cette \u00e9tude est d'\u00e9valuer le rapport co\u00fbt-efficacit\u00e9 du traitement anti-VHC et d'estimer sa charge \u00e9conomique en Turquie.<\/p>\n\n\n\n

M\u00e9thodes<\/h3>\n\n\n\n

Un mod\u00e8le de progression de la maladie bas\u00e9 sur Excel a \u00e9t\u00e9 utilis\u00e9 pour estimer la population infect\u00e9e par le VHC pour 2015-2030. Les co\u00fbts directs en dollars am\u00e9ricains (USD), y compris les co\u00fbts de diagnostic, de laboratoire et de soins de sant\u00e9, ont \u00e9t\u00e9 fournis par des experts du pays. Les co\u00fbts indirects ont \u00e9t\u00e9 estim\u00e9s en tant que perte de productivit\u00e9 \u00e0 l'aide de la mesure des ann\u00e9es de vie ajust\u00e9es en fonction de l'incapacit\u00e9 (DALY) de l'Organisation mondiale de la sant\u00e9 (OMS) de l'\u00e9tude Global Burden of Disease. Trois sc\u00e9narios ont \u00e9t\u00e9 \u00e9labor\u00e9s pour estimer le rapport co\u00fbt-efficacit\u00e9 du traitement contre le VHC jusqu'en 2030: Base 2016, Augmenter le traitement et la RVS (o\u00f9 la RVS est une r\u00e9ponse virologique soutenue) et les objectifs de l'OMS. En outre, le sc\u00e9nario des objectifs de l'OMS a \u00e9t\u00e9 \u00e9valu\u00e9 \u00e0 trois niveaux de prix de traitement diff\u00e9rents: 10 900 USD, 16 730 USD (co\u00fbt de base) et 27 285 USD.<\/p>\n\n\n\n

R\u00e9sultats<\/h3>\n\n\n\n

Les co\u00fbts directs et indirects totaux cumul\u00e9s (2015-2030) pour le sc\u00e9nario des objectifs de l'OMS ont \u00e9t\u00e9 estim\u00e9s \u00e0 10,8 milliards USD, soit une augmentation de 1,5 % par rapport \u00e0 la base 2016. Cependant, d'ici la d\u00e9cennie suivante, en raison d'une baisse marqu\u00e9e des DALY, cumulatif Les co\u00fbts directs et indirects ont \u00e9t\u00e9 estim\u00e9s \u00e0 45 % de moins par rapport \u00e0 la base 2016. \u00c0 un seuil de 9125 USD, tous les sc\u00e9narios \u00e9taient rentables.<\/p>\n\n\n\n

Conclusions<\/h3>\n\n\n\n

En mettant en \u0153uvre le sc\u00e9nario des objectifs de l\u2019OMS, la Turquie serait en mesure de r\u00e9duire la pr\u00e9valence du VHC de 80 % et de r\u00e9duire le nombre total de d\u00e9c\u00e8s li\u00e9s au foie de > 65 % d\u2019ici 2030. Le traitement de l\u2019infection par le VHC dans le pays est rentable si les soins de sant\u00e9 et les co\u00fbts indirects sont pris en compte.<\/p>\n\n\n\n

Des pays:<\/strong> dinde<\/p>\n\n

\n
Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Background Hepatitis C virus (HCV) infection is a significant health problem. The aim of this study is to evaluate the cost-effectiveness of HCV treatment and estimate its economic burden in Turkey. Methods An Excel-based disease progression model was used to estimate the HCV-infected population for 2015-2030. Direct costs in US dollars (USD) including diagnostic, […]<\/p>\n","protected":false},"author":24,"featured_media":3375,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[32,10],"publication-author":[1040,1042,1041,1039,494,807],"class_list":["post-2550","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-economic-impact","tag-hcv","publication-author-balik-i","publication-author-ergor-g","publication-author-malhan-s","publication-author-ormeci-n","publication-author-razavi-h","publication-author-robbins-s"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2550"}],"version-history":[{"count":7,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2550\/revisions"}],"predecessor-version":[{"id":7556,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2550\/revisions\/7556"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3375"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2550"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}